Provision of pharmaceutical services
paragraph 4(11)(b) of SCHEDULE 1 of The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009
- Status not determined
- Strict liability
- Drugs and medicines
This offence was read from the text as made, and no revised version was available, so a later revocation could not be ruled out. Check the current text at legislation.gov.uk.
What the provision says
b the person presenting the prescription form or serial prescription, or requesting the provision of drugs or appliances in accordance with an electronic prescription form or serial prescription, or any other person accompanying that person, commits or threatens to commit
a criminal offence.
Text as made, from legislation.gov.uk. © Crown copyright, reused under the Open Government Licence v3.0. This is the text as originally made; later amendments are not shown here.
Who it binds, and what has to be proved
- Binds
- a person
- Conduct
- breaching the provision
- Fault element
- Strict liability
- Burden of proof
- No statutory defence — prosecution proves everything
The prosecution must prove that the conduct happened. This is a strict liability offence as drafted: the provision uses no word of intention, knowledge, recklessness or negligence, so there is no need to show that a person meant to do it, knew about it, or was careless.
Intention, knowledge and carelessness are irrelevant to guilt. They may still matter a great deal to sentence.
The provision states no defence, so the prosecution bears the burden on every element of the offence.
Classifier’s reasoning: no word of intention, knowledge, recklessness or negligence in the offence or its provision.
What would breach paragraph 4(11)(b) of SCHEDULE 1?
These are illustrations, not law. They are generated from the provision’s own words to show the shape of the offence. Whether any particular conduct is caught depends on the full text, on any amendment since, and on the facts.
- Doing what the provision prohibits, or failing to do what it requires under the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009.
Penalty
- Mode of trial
- Not determined
- Maximum fine
- Not determined
- Maximum prison (summary)
- Not determined
no penalty is stated in this instrument; it may be in the enabling Act, or in a general penalties provision this pass did not connect to the offence.
No penalty was determined from this instrument. It may be in the enabling Act, or in a general penalties provision this pass did not connect to the offence. Absence of a figure here is not evidence that the offence carries no penalty.
Sentencing
Offences of this kind are usually sentenced under the guidelines below. This is a mapping by subject, not a finding about this provision, and the links go to a search of the Sentencing Council’s own site.
-
Drug offences: definitive guideline
Magistrates' courts and the Crown Court in England and Wales
Covers importation, supply, production and possession of controlled drugs, with sentencing driven by drug class and the offender's role.
-
Reduction in sentence for a guilty plea: definitive guideline
All courts in England and Wales · in force from 1 June 2017
The sliding scale of credit for pleading guilty, from one third at the first stage of proceedings downwards.
-
General guideline: overarching principles
All courts in England and Wales · in force from 1 October 2019
The guideline a court uses when there is no offence-specific guideline, which is the position for the overwhelming majority of offences created by statutory instrument. It sets out how culpability and harm are assessed from first principles.
-
Totality: definitive guideline
All courts in England and Wales
How to sentence more than one offence at once so that the total is just and proportionate - frequently in point here, because regulatory prosecutions commonly charge several breaches of the same instrument.
Prosecution figures
No published per-offence figure was found for this provision, and it could not be matched to a Ministry of Justice offence code. Offences created by statutory instrument very largely do not have one. Absence of a figure is not evidence that the offence is unused.
Status and lifecycle
- Current status
- Status not determined
- Made
- 14 May 2009
- In force from
- 1 July 2009
- Extent
- Not stated
How this was established: read from the text as made; no revised version available, so later revocation could not be ruled out.
What the instrument is for
(This note is not part of the Regulations) — the explanatory note published with the instrument, © Crown copyright.
These Regulations consolidate, with amendments, the National Health Service (Pharmaceutical Services) (Scotland) Regulations 1995 (“the 1995 Regulations”) and all subsequent amendments to them are revoked by regulation 17 and Schedule 5. These Regulations now regulate the terms on which pharmaceutical services are provided under the National Health Service (Scotland) Act 1978. The “Drug Tariff” referred to in regulation 12 is published monthly as a web-based version at – http://www.isdscotland.org/isd/2245.html. An annual hard copy is published on 1st April each year. To be added to the mailing list for the hard copy distribution, email: evadis@isd.csa.scot.nhs.uk. Amendments to the 1995 Regulations in this consolidation are largely minor or consequential drafting amendments. This includes a number of defined terms that have been added to, or updated, in regulation 2 (Interpretation and application). The terms and conditions for pharmacists and pharmacy contractors (Schedule 1, paragraph 4) have been amended to include provisions relating to the provision of a Chronic Medication Service (CMS). CMS is the provision by a pharmacist of pharmaceutical care to patients with long term conditions who have registered with that pharmacist for the CMS. The terms and conditions for pharmacists and pharmacy contractors also now include a requirement to keep appropriate records for at least seven years which must be made available for inspection on request by the Scottish Ministers, the relevant Health Board or the Common Services Agency. Pharmacy contractors must also designate a person engaged by them to hold responsibility for maintaining confidentiality of patient data (Schedule 1, paragraph 14). A duty on Health Boards to consult with the public when determining applications to be included in the pharmaceutical list is now provided for in paragraph 2 of Schedule 3.
Read the full note and every offence in this instrument
Other offences in the same instrument
- Provision of pharmaceutical servicesparagraph 4(11) of SCHEDULE 1
How this was identified as an offence
Everything above rests on the judgement that this provision creates a criminal offence, rather than mentioning one. That judgement is made by rule, from the words of the provision, and this is the rule that made it — with a confidence of 0.92.
- Basis
- the provision says a person “commits an offence”
- Confidence
- 0.92 of 1.00
A provision that states a penalty for an offence created elsewhere can read very like one that creates an offence, and the rules can mistake the one for the other. If the text quoted above sets a penalty for something made an offence by another provision, treat the classification on this page with that in mind, and read the instrument.
Check the source
- This provision on legislation.gov.uk The authoritative text. Check it before relying on anything here.
- The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 Every offence this instrument creates, and its explanatory note
- Drugs and medicinesOther offences on the same subject
- Offences created in 2009